Literature DB >> 27345394

Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis.

C Anadón, S Guil, L Simó-Riudalbas, C Moutinho, F Setien, A Martínez-Cardús, S Moran, A Villanueva, M Calaf, A Vidal, P A Lazo, I Zondervan, S Savola, T Kohno, J Yokota, L Ribas de Pouplana, M Esteller.   

Abstract

Entities:  

Year:  2016        PMID: 27345394      PMCID: PMC4994013          DOI: 10.1038/onc.2016.27

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


× No keyword cloud information.
Correction to: Oncogene advance online publication 7 December 2015; doi:10.1038/onc.2015.469 Following the online publication of this article one of the authors noticed an error in the presentation of their name. The name has now been corrected to L Ribas de Pouplana. The authors apologise for any inconvenience caused by this error. This error has now been rectified, and the corrected article appears in this issue. The html and online pdf versions have also been rectified, and now carry the corrected paper.
  10 in total

1.  The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizing FAK.

Authors:  Elianna M Amin; Yuan Liu; Su Deng; Kay See Tan; Neel Chudgar; Marty W Mayo; Francisco Sanchez-Vega; Prasad S Adusumilli; Nikolaus Schultz; David R Jones
Journal:  Sci Signal       Date:  2017-09-19       Impact factor: 8.192

2.  RNA modifications and cancer.

Authors:  Phensinee Haruehanroengra; Ya Ying Zheng; Yubin Zhou; Yun Huang; Jia Sheng
Journal:  RNA Biol       Date:  2020-02-07       Impact factor: 4.652

3.  Tissue and exosomal miRNA editing in Non-Small Cell Lung Cancer.

Authors:  Giovanni Nigita; Rosario Distefano; Dario Veneziano; Giulia Romano; Mohammad Rahman; Kai Wang; Harvey Pass; Carlo M Croce; Mario Acunzo; Patrick Nana-Sinkam
Journal:  Sci Rep       Date:  2018-07-05       Impact factor: 4.379

4.  ADAR1 may be involved in the proliferation of acute myeloid leukemia cells via regulation of the Wnt pathway.

Authors:  Han Xiao; Qian Cheng; Xinyu Wu; Yishu Tang; Jing Liu; Xin Li
Journal:  Cancer Manag Res       Date:  2019-09-20       Impact factor: 3.989

Review 5.  Pathogenic diversity of RNA variants and RNA variation-associated factors in cancer development.

Authors:  Hee Doo Yang; Suk Woo Nam
Journal:  Exp Mol Med       Date:  2020-04-28       Impact factor: 8.718

6.  8-Chloro-Adenosine Inhibits Proliferation of MDA-MB-231 and SK-BR-3 Breast Cancer Cells by Regulating ADAR1/p53 Signaling Pathway.

Authors:  Hong-Yue Ding; Wan-Yong Yang; Li-Hong Zhang; Li Li; Feng Xie; Hua-Yi Li; Xiao-Yu Chen; Zeng Tu; Yi Li; Yong Chen; Sheng-Yong Yang
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

7.  DNA repair glycosylase hNEIL1 triages damaged bases via competing interaction modes.

Authors:  Menghao Liu; Jun Zhang; Chenxu Zhu; Xiaoxue Zhang; Weide Xiao; Yongchang Yan; Lulu Liu; Hu Zeng; Yi Qin Gao; Chengqi Yi
Journal:  Nat Commun       Date:  2021-07-05       Impact factor: 14.919

8.  Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration.

Authors:  Jennifer B Permuth; Brett Reid; Madalene Earp; Y Ann Chen; Alvaro N A Monteiro; Zhihua Chen; Georgia Chenevix-Trench; Peter A Fasching; Matthias W Beckmann; Diether Lambrechts; Adriaan Vanderstichele; Els Van Niewenhuyse; Ignace Vergote; Mary Anne Rossing; Jennifer Anne Doherty; Jenny Chang-Claude; Kirsten Moysich; Kunle Odunsi; Marc T Goodman; Yurii B Shvetsov; Lynne R Wilkens; Pamela J Thompson; Thilo Dörk; Natalia Bogdanova; Ralf Butzow; Heli Nevanlinna; Liisa Pelttari; Arto Leminen; Francesmary Modugno; Robert P Edwards; Roberta B Ness; Joseph Kelley; Florian Heitz; Beth Karlan; Jenny Lester; Susanne K Kjaer; Allan Jensen; Graham Giles; Michelle Hildebrandt; Dong Liang; Karen H Lu; Xifeng Wu; Douglas A Levine; Maria Bisogna; Andrew Berchuck; Daniel W Cramer; Kathryn L Terry; Shelley S Tworoger; Elizabeth M Poole; Elisa V Bandera; Brooke Fridley; Julie Cunningham; Stacey J Winham; Sara H Olson; Irene Orlow; Line Bjorge; Lambertus A Kiemeney; Leon Massuger; Tanja Pejovic; Melissa Moffitt; Nhu Le; Linda S Cook; Angela Brooks-Wilson; Linda E Kelemen; Jacek Gronwald; Jan Lubinski; Nicolas Wentzensen; Louise A Brinton; Jolanta Lissowska; Hanna Yang; Estrid Hogdall; Claus Hogdall; Lene Lundvall; Paul D P Pharoah; Honglin Song; Ian Campbell; Diana Eccles; Iain McNeish; Alice Whittemore; Valerie McGuire; Weiva Sieh; Joseph Rothstein; Catherine M Phelan; Harvey Risch; Steven Narod; John McLaughlin; Hoda Anton-Culver; Argyrios Ziogas; Usha Menon; Simon Gayther; Susan J Ramus; Aleksandra Gentry-Maharaj; Celeste Leigh Pearce; Anna H Wu; Jolanta Kupryjanczyk; Agnieszka Dansonka-Mieszkowska; Joellen M Schildkraut; Jin Q Cheng; Ellen L Goode; Thomas A Sellers
Journal:  Oncotarget       Date:  2016-11-08

Review 9.  Epitranscriptomics of cancer.

Authors:  Marina Tusup; Thomas Kundig; Steve Pascolo
Journal:  World J Clin Oncol       Date:  2018-06-10

Review 10.  Non-Coding RNAs in Lung Tumor Initiation and Progression.

Authors:  Ruben Mercado Santos; Cerena Moreno; Wen Cai Zhang
Journal:  Int J Mol Sci       Date:  2020-04-16       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.